Home  >  Products  >  EAF2 (ELL associated factor 2 ) Blocking Peptide (the C terminal of EAF2)(100ug)
EAF2 (ELL associated factor 2 ) Blocking Peptide (the C terminal of EAF2)(100ug)

EAF2 (ELL associated factor 2 ) Blocking Peptide (the C terminal of EAF2)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-EAF2 Antibody (ARP64761_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP64761
Size: 100ug
Weight: 29kDa
Gene: 55840
Format: Lyophilized powder
Target: EAF2 acts as a transcriptional transactivator of TCEA1 elongation activity and a transcriptional transactivator of ELL and ELL2 elongation activities. EAF2 is a potent inducer of apoptosis in prostatic and non-prostatic cell lines and inhibits prostate tumor growth in vivo.
Alternative names: BM040; TRAITS; U19
See Full Product Listings >